Pulmonary Emboli and Deep Vein Thromboses: Are They Always Part of the Same Disease Spectrum?

Similar documents
4. Which survey program does your facility use to get your program designated by the state?

Clinical Implications of the Impact of Serum Tissue Factor Levels after Trauma

ACUTE KIDNEY INJURY (AKI) ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) ADVANCED DIRECTIVE LIMITING CARE...91 AGE...9 AGE UNITS...

Post-Traumatic Thromboembolism. Pathogenesis, Diagnosis and Prevention M. Margaret Knudson, MD

Q1 Contact Information

THROMBOEMBOLIC EVENTS AFTER IVC FILTER PLACEMENT IN TRAUMA PATIENTS. Lidie Lajoie, MD SUNY Downstate Department of Surgery December 20, 2012

A Comparative Analysisof Male versus Female Breast Cancer in the ACS NSQIP Database

EAST MULTICENTER STUDY DATA DICTIONARY

Inferior Venacaval Filters Valuable vs. Dangerous Valuable Annie Kulungowski. Department of Surgery Grand Rounds March 24, 2008

Predicting Short Term Morbidity following Revision Hip and Knee Arthroplasty

Massive Transfusion in Pediatric Trauma: Analysis of the National Trauma Databank

Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass?

Dr. Rami M. Adil Al-Hayali Assistant Professor in Medicine

CURRENT & FUTURE THERAPEUTIC MANAGEMENT OF VENOUS THROMBOEMBOLISM. Gordon Lowe Professor of Vascular Medicine University of Glasgow

The Michigan Trauma Quality Improvement Program. Ann Arbor, MI June 7, 2011

VTE Management in Surgical Patients: Optimizing Prophylaxis Strategies

Prevention of Venous Thromboembolism in High-Risk Patients

VTE in the Trauma Population

ACS-NSQIP 2015 Julietta Chang MD, Ali Aminian MD, Stacy A Brethauer MD, Philip R Schauer MD Bariatric and Metabolic Institute

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Thrombolysis in PE. Outline. Disclosure. Overview on Pulmonary Embolism. Hot Topics in Emergency Medicine 2012 Midyear Clinical Meeting

Disclosures. DVT: Diagnosis and Treatment. Questions To Ask. Dr. Susanna Shin - DVT: Diagnosis and Treatment. Acute Venous Thromboembolism (VTE) None

The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters.

VTE in Children: Practical Issues

Ischemic Stroke in Critically Ill Patients with Malignancy

Misunderstandings of Venous thromboembolism prophylaxis

Venous thrombotic, thromboembolic, and mechanical complications after retrievable inferior vena cava filters for major trauma

Inferior Vena Cava Filters

Top Ten Reasons For Failure To Prevent Postoperative Thrombosis

How long to continue anticoagulation after DVT?

Chapter 1. Introduction

Cover Page. The handle holds various files of this Leiden University dissertation

Outcomes of Patients with Preoperative Weight Loss following Colorectal Surgery

DVT Pathophysiology and Prophylaxis in Medically Hospitalized Patients. David Liff MD Oklahoma Heart Institute Vascular Center

Risk factors for DVT. Venous thrombosis & pulmonary embolism. Anticoagulation (cont d) Diagnosis 1/5/2018. Ahmed Mahmoud, MD

Venous thrombosis & pulmonary embolism. Ahmed Mahmoud, MD

Thromboembolic events (TEs), such as deep vein

PROGNOSIS AND SURVIVAL

IVC FILTERS: A CASE REPORT REVIEWING THE INDICATIONS FOR PLACEMENT, RETRIEVAL AND ANTICOAGULATION

PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM

Symptomatic Venous Thromboembolism after Total Hip/Knee Replacement: A Population-based Taiwan Study

Predicting Venous Thromboembolic Complications following Neurosurgical Procedures

VENOUS THROMBOEMBOLISM: DURATION OF TREATMENT

I am NOT: Disclosures. The Problem of the Con-Position Non Thinking! Against New Ideas. Against New Therapies. Against Endovascular Therapies

Early Ambulation Reduces the Risk of Venous Thromboembolism After Total Knee Replacement. Marilyn Szekendi, PhD, RN

Venous Thromboembolism Among Military Combat Casualties

Mabel Labrada, MD Miami VA Medical Center

PE and DVT. Dr Anzo William Adiga WatsApp or Call Medical Officer/RHEMA MEDICAL GROUP

Online Supplementary Data. Country Number of centers Number of patients randomized

Pulmonary Embolism. Pulmonary Embolism. Pulmonary Embolism. PE - Clinical

Handbook for Venous Thromboembolism

Epidemiology: Incidence VTE: Mortality Morbidity Risk Factors: Acute Chronic : Genetic

VENOUS THROMBOEMBOLISM AND CORONARY ARTERY DISEASE: IS THERE A LINK?

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

Pathology of pulmonary vascular disease. Dr.Ashraf Abdelfatah Deyab. Assistant Professor of Pathology Faculty of Medicine Almajma ah University

The Efficacy of Early anticoagulant Therapy for Venous Thromboembolism in Polytrauma Patients in the acute Phase

PULMONARY EMBOLISM (PE): DIAGNOSIS AND TREATMENT

TITLE: Acetylsalicylic Acid for Venous Thromboembolism Prophylaxis: A Review of Clinical Evidence, Benefits and Harms

Bath, Philip M.W. and England, Timothy J. (2009) Thighlength compression stockings and DVT after stroke. Lancet. ISSN (In Press)

Is Thrombolysis Only for a Crisis?

Clinical Practice Management Guideline for Venous Thromboembolism Prevention

Slide 1. Slide 2. Slide 3. Outline of This Presentation

Contents. Version 1.0: 01/02/2010 Protocol# ISRCTN Page 1 of 7

Thrombosis and emboli. Peter Nagy

Ultrasound-enhanced, catheter-directed thrombolysis for pulmonary embolism

Epidemiologia e clinica del tromboembolismo venoso. Maria Ciccone Sezione di Ematologia e Fisiopatologia della Coagulazione

Cardiovascular Disease

Outcomes of Therapeutic Hypothermia in Cardiac Arrest. Saad Mohammed Shariff, MBBS Aravind Herle, MD, FACC

Venous Thrombosis. Magnitude of the Problem. DVT 2 Million PE 600,000. Death 60,000. Estimated Cost of VTE Care $1.5 Billion/year.

Dr Yuen Wai-Cheung HA Convention 2011

Cover Page. The handle holds various files of this Leiden University dissertation.

Specific Aims: Trauma has been identified as a prothrombotic state that increases the risk of venous thrombosis and pulmonary embolism (VTE), both of

Venous Thrombo-Embolism. John de Vos Consultant Haematologist RSCH

1. SCOPE of GUIDELINE:

ORIGINAL ARTICLE. Prevalence and Implications of Preinjury Warfarin Use

October 2017 Pulmonary Embolism

RISK STRATIFICATION OF PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM. David Jiménez, MD, PhD, FCCP Ramón y Cajal Hospital, IRYCIS Madrid, Spain

UPDATES, 2018 NTDS PILOT (PROPOSED CHANGES TO 2020 NTDB DATA DICTIONARY) AND TQIP PROCESS MEASURES. Lita Holdeman, BS, CSTR AOTR Education Chair

Title: Low Molecular Weight Heparins (LMWH), fondaparinux (Arixtra)

Prevention and management of deep venous thrombosis (DVT) John Fletcher Wound Care Association of New South Wales

DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service

Supplemental Appendix. 1. Protocol Definition of Sustained Virologic Response. A patient has a sustained virologic response if:

The Impact of Chronic Liver Disease on Postoperative Outcomes and Resource Utilization within the National Surgical Quality Improvement Database

Neurosurgical patients are at risk for developing

Single Center 4 year series of 114 consecutive patients treated for massive and submassive PE. Mark Goodwin, MD

Cover Page. The handle holds various files of this Leiden University dissertation.

Innovative Endovascular Approach to Pulmonary Embolism by Ultrasound Enhanced Thrombolysis. Prof. Ralf R.Kolvenbach MD,PhD,FEBVS

Venous Thromboembolism Prophylaxis

INFERIOR VENA CAVA FILTERS QUIZ 10 QUESTIONS MAY 5, 2014

REVIEW ON PULMONARY EMBOLISM

Chapter 8: Cardiovascular Disease in Patients with ESRD

Ryan Walsh, MD Department of Emergency Medicine Madigan Army Medical Center

LIMB COMPRESSION DEVICES FOR VENOUS THROMBOEMBOLISM PROPHYLAXIS

Clinical Guide - Inferior Vena Cava Filters (Reviewed 2006)

Chapter 9: Cardiovascular Disease in Patients With ESRD

Chapter 2 Triage. Introduction. The Trauma Team

Review of Surgical Treatment of Popliteal Artery Injury: Outcomes of Open vs Endovascular Repair

CPT only copyright 2014 American Medical Association. All rights reserved. 12/23/2014 Page 66 of 593

Comorbidity or medical history Existing diagnoses between 1 January 2007 and 31 December 2011 AF management care AF symptoms Tachycardia

EAST MULTICENTER STUDY DATA DICTIONARY. Temporary Intravascular Shunt Study Data Dictionary

Transcription:

MILITARY MEDICINE, 181, 5:104, 2016 Pulmonary Emboli and Deep Vein Thromboses: Are They Always Part of the Same Disease Spectrum? Nicole T. Gordon, MD; COL Martin A. Schreiber, MC USAR ABSTRACT Background: Pulmonary embolis (PEs) are thought to emanate from deep vein thromboses (DVTs). Government agencies now use thromboembolic events as a quality metric for reimbursement for care. Recent data suggest that PEs and DVTs may represent different pathologic processes. We sought to identify separate risk factors for PEs and DVTs to test whether they are the same disease process. Methods: A retrospective review of the National Trauma Data Bank between 2007 and 2010 was performed. Demographics, complications, comorbidities, and injury data were reviewed for risk factors for patients diagnosed with a PE or DVT. Results: After exclusion criteria were met 521,969 patient entries were analyzed. Of these patients, 4,154 and 1,460 had a DVT or PE, respectively,while 8% (433) of patients had both. PEs and DVTs, had 18 overlapping risk factors, 26 independent risk factors (5 for PEs; 21 for DVTs), and one divergent risk factor. Conclusion: Despite PEs and DVTs having overlapping risk factors, there are significant independent and divergent risk factors for the two diseases, suggesting that they are not always part of the same process. The constellation of risk factors for each disease may help to predict which one patient is predisposed to and draws into question the concept of using them as a quality metric as whether therapeutic anticoagulation is indicated in trauma patients. INTRODUCTION Pulmonary embolis (PEs) as a result of dislodgement of clot from deep vein thromboses (DVTs) were originally described by Dr. Rudolph Virchow in 1845. 1 Since his discovery, there has been little change in the thought process surrounding the pathophysiology of venous thromboembolism (VTE). It was not until the advent of computed tomography (CT) scans when questions started to arise regarding how related were the two diagnoses. In 2009, a retrospective review of trauma patients who underwent CT imaging of the chest and lower extremities in an effort to diagnose patients with a PE and source of the embolism showed little overlap in the number of patients diagnosed with a PE and DVT. 2 The authors hypothesized that PEs could be the result of a primary pulmonary artery thrombosis rather than a dislodged embolus from DVTs. However, no significant different risk factors were identified in patients with only a PE or a DVT. More recent studies have started to identify independent different risk factors for patients diagnosed with each disease entity. 3 5 In general, trauma patients diagnosed with a PE tend to have more severe chest injury, whereas patients with a DVT have a more varied injury pattern, and benefit from prophylaxis within 48 hours. However, criticisms of these studies include the selection process for risk factors and the failure to control for confounding variables. For certain studies, candidate risk factors were limited to known causes of VTE. By limiting a study to only known risks factors, it is possible that other Division of Trauma, Critical Care and Acute Care Surgery, Department of General Surgery, Oregon Health and Science University, Portland, OR 97239. This work was presented at the Military Health Systems Research Symposium, Fort Lauderdale, FL, August 20, 2014. doi: 10.7205/MILMED-D-15-00156 critical modifiable ones could be missed. Furthermore, in addition to limiting risk factors to only known causes of VTE, other studies did not clearly state the selection process for which risk factors to study. The clinical relevance of questioning whether the two disease processes are always related is two-fold. First, if a patient developed a de novo pulmonary thrombus (DNPT), it draws into question whether therapeutic anticoagulation or an inferior vena cava (IVC) filter is indicated. Combat patients have a higher risk of developing a VTE compared to the civilian. 6 Limiting therapeutic anticoagulation and IVC filters in patients with DNPTs curtails the associated risk with their use, especially in a combat trauma patient that is at risk of bleeding. In addition, if DNPTs do occur, it challenges the use of VTE as a metric for quality-based reimbursed care. The government initiated Agency for Healthcare Research and Quality considers PEs as the most common preventable cause of hospital death. 7 The Centers for Medicare and Medicaid Services has started to view PEs in certain postoperative patients as a never event and has limited reimbursement for treatment of PEs in these patients. 8 The objective of this study was to further test whether PEs and DVTs are always related by reviewing all risk factors associated with admission characteristics and all listed comorbidities and complications tracked by the National Trauma Data Bank (NTDB). All discovered risk factors would then be subjected to a multivariate analysis to control for confounding variables. We hypothesize that trauma patients diagnosed with DVTs or PEs will have different risk factors, which may suggest that they are not always the same process. METHODS With Institutional Review Board approval, we tested our hypothesis by using the data set provided by the American 104

College of Surgeons NTDB between 2007 and 2010. These years were used as they consistently reported data in the same fashion. All patients within the databank that had all data points studied were included. Exclusion criteria included patients who were less than 18 years of age and those who expired in the emergency department or within 2 days of admission. All complications and comorbidities that are tracked within the NTDB were candidate risk factors. These are listed in Table I. To account for quality control of the database as previously described, 9 only patients who were cared for at level I and II trauma centers were studied as they were most likely to report complications and comorbidities. Patients who were cared for by centers that did not report the most common complication (pneumonia) or comorbidity (hypertension) within the years of the NTDB datasets that TABLE I. National Trauma Data Bank Studied Comorbidities and Complications Comorbidities No NTDS Comorbidity Present Alcoholism Ascites Within 30 Days Bleeding Disorder Chemotherapy for Cancer Within 30 Days Congenital Anomalies Congestive Heart Failure Current Smoker Currently Requiring or on Dialysis CVA/Residual Neurological Deficit Diabetes Mellitus Disseminated Cancer Do not Resuscitate Status Esophageal Varices Functionally Dependent Health Status History of Angina within Past 1 Month History of MI within the Past 6 Months History of Revascularization/ Amputation for PVD Hypertension Requiring Medication Impaired Sensorium Prematurity Obesity Respiratory Disease Steroid Use Complications No NTDS Complication Present Abdominal Compartment Syndrome Abdominal Fascia Left Open Acute Renal Failure ARDS Base Deficit Bleeding Cardiac Arrest With CPR Coagulopathy Coma Decubitus Ulcer Deep Surgical Site Infection Drug or Alcohol Withdrawal Syndrome DVT/Thrombophlebitis Extremity Compartment Syndrome Graft/Prosthesis/Flap Failure Intracranial Pressure Myocardial Infarction Organ/Space Surgical Site Infection Pneumonia Pulmonary Embolism Stroke/CVA Superficial Surgical Site Infection Systemic Sepsis Unplanned Intubation Wound Disruption NTDB, National Trauma Data Bank; CVA, cerebrovascular accident; MI, myocardial infarction; PVD, peripheral vascular disease; ARDS, acute respiratory distress syndrome; CPR, cardiopulmonary resuscitation; DVT = deep vein thrombosis. were used, were also excluded given that if they do not report the most common complication they are likely not to report any in general. In addition, centers that were designated by the NTDB as those that do not submit complication or comorbidity data were excluded from the study. Patient diagnosed with a PE or DVT was identified. Patients diagnosed with a PE were identified by using the International Classification of Diseases, 9 th revision codes for PE (415.1, 415.11, and 415.19) and patients who were diagnosed as having a PE as an NTDB complication. Patients diagnosed with septic PE were not included in the study. Patients diagnosed with a DVT were identified by International Classification of Diseases, 9 th revision codes (451.11, 451.19, 451.2, 451.81, 453.2, 453.8, 453.9, 451.83, 541.89, and 451.84) as well as patients who were identified as having a DVT as an NTDB complication. Variables studied were all NTDB comorbidities and complications tracked within the database, demographics of the patients including age (treated as a continuous variable), gender, race, and mechanism of injury. The highest abbreviated injury scale (AIS) score per region, the Glasgow Coma Scale (GCS) score, and patient vitals on arrival were included in the analysis. All comorbidities and complications that are specifically tracked in the NTDB annually were included as many were considered risk factors for VTEs. The study was not limited to known causes of VTE to decrease the possibility of biasing the study toward known risk factors thereby eliminating other potential ones from being discovered. Statistical analysis was performed using SPSS (version 21) (IBM Corporation, Armonk, New York). All risk factors were subjected to a univariate analysis with significance being defined as a p value of less than 0.20. Afterward, a multivariate backward logistic regression was used to control for confounding variables. Significance was defined as a p value less than 0.05. All risk factors were studied for each patient population. RESULTS The total NTDB cohort studied included 1.1 million patients. After exclusion criteria were implemented, 521,000 patients remained in the study. Demographics are listed in Table II. The mean age was 42 years, the mean Injury Severity Score was 9, and 64% of the population were males. Blunt injury accounted for the most common mechanism of injury. There were 4,154 patients diagnosed with a DVT, 1,460 patients with a PE, and there were 433 patients diagnosed with both a PE and DVT, indicating an 8% overlap in patients who were diagnosed with both a PE and DVT. PEs and DVTs had 18 overlapping risk factors, 26 independent risk factors (5 for PEs; 21 for DVTs), and one divergent risk factor. Demographic and clinical characteristics at the time of presentation are listed in Table III. Significant risk factors for thromboembolism were gender, with the female gender having a decreased odds ratio for developing a DVT or PE, when compared to males as a reference. Race was also a risk 105

TABLE II. Demographics for the Studied Patient Cohort. Other Mechanism of Injury Included: Adverse Drug Effect, Adverse Medical Care, Drowning/Submersion, National/Environmental Injury Including Bites and Stings, Overexertion, Poisoning, Suffocation, and Unspecified Demographics Age, Mean (SD) 42 (24) Gender, M:F% 64:36 Race, % White 71.6 Black 15.8 Asian 1.6 American Indian 0.9 Other 9.9 Mechanism of Injury, % Blunt 83.5 Penetrating 9.8 Bum 2.2 Other 4.6 ISS, Mean (SD) 9 (8) ISS, Injury Severity Score; SD, standard deviation. factor with American Indians and Asians having odds ratios of 0.5 and 0.7 ( p value <0.02) when compared to white patients for developing a DVT. Black race was not a significant risk factor for developing a VTE compared to whites with an odds ratio of 1 and a p value of 0.99. Increasing age was also associated with developing a VTE with a 1 to 2% increased risk per additional year of life on presentation to the emergency department ( p value <0.01). With regard to vitals on arrival, a patient with hypotension (systolic blood pressure <90 mm Hg) had an odds ratio of 1.18 (confidence interval [CI] = 1.01, 1.39) compared to a normotensive patient. Worsening tachycardia and GCS were also associated with an increased risk of a VTE event. However, a worsening GCS score was more predictive of a DVT than a PE, as is indicated by a near 70% increased risk of developing a DVT compared to a PE in the most severely head injured patients (GCS score of <4). In this patient population, the CIs did not overlap. The odds ratio of developing a DVT was 2.05 (CI = 1.86, 2.26) compared to 1.37 (CI = 1.14, 1.64) in patients diagnosed with a PE, suggesting that the risk is different between the 2 groups in the most severely head injured patients. Remaining risk factors for each patient population are listed in Table IV. There were 19 and 5 risk factors that were associated with developing a DVT and PE, respectively. Mechanism of injury is listed as separate risk factor for each group, as a different mechanism was either predictive or protective for a PE or DVT. Relative to blunt injury, a penetrating injury was associated with an odds ratio of 1.64 (CI = 1.46, 1.85) for being diagnosed with a DVT, and it was not predictive for developing a PE. All comorbidity and complications associated with developing a DVT had an increased odds ratio except for patients who were designated with a do not resuscitate code status. This risk factor was associated with a decreased odds ratio of 0.21 (CI = 0.08, 0.58). With regard to the comorbidities of chemotherapy, steroid use, bleeding disorders, dialysis, TABLE III. Demographic and Presenting Emergency Department Clinical Characteristics (e.g., Vitals and Glasgow Coma Scale Score) Risk Factors Associated with Developing a Deep Vein Thrombosis, Pulmonary Emboli, or Both. All Risk Factors Were Subjected to a Multivariate Logistic Regression. p 0.02 for All Risk Factors Except for Hypotension, for Which p = 0.04 Nature of Risk Factor Risk Factor OR Lower Upper OR Lower Upper Demographics Age 1.02 1.01 1.02 1.01 1.01 1.02 Gender 0.68 0.63 0.73 0.74 0.66 0.83 Race White Ref American Indian 0.48 0.28 0.82 Asian 0.69 0.51 0.94 Black Other Race Systolic Blood Pressure Normotensive (SBP 80 130 mm Hg) Ref Hypotensive (SBP <80 mm Hg) 1.18 1.01 1.39 Hypertensive (SBP >130 mm Hg) 0.89 0.83 0.95 Heart Rate Normal Pulse (60 100 bpm) Ref Tachycardia (100 120 bpm) 1.23 1.13 1.33 1.25 1.09 1.42 Severe Tachycardia (>120 bpm) 1.36 1.23 1.51 1.29 1.08 1.54 GCS Score GCS Score 13 15 Ref GCS Score 9 12 1.67 1.44 1.95 1.53 1.18 1.99 GCS Score 5 8 2.05 1.76 2.39 1.45 1.07 1.97 GCS Score <4 2.05 1.86 2.26 1.37 1.14 1.64 DVT PE DVT, deep vein thrombosis; PE, pulmonary emboli; bpm, beats per minute; OR, odds ratio; SBP, systolic blood pressure; GCS, Glasgow Coma Scale. 106

TABLE IV. Risk Factors That Are Associated with Developing a Deep Vein Thrombosis, Pulmonary Emboli, or a DVT or Both Simultaneously. All Risk Factors Have Been Subjected to Multivariate Logistic Regression DVT PE DVT Risk Factors Risk Factor OR Lower Upper OR Lower Upper Severe Injury Severe Head Injury (AIS 3) 2.41 2.23 2.6 Severe Neck Injury (AIS 3) 1.61 1.22 2.11 Comorbidities Chemotherapy Within 30 Days 2.31 1.2 4.45 Steroid Use 1.61 1.02 2.53 Bleeding Disorder 1.5 1.31 1.71 Dialysis Use 1.49 1.05 2.13 CVA/Residual Neurological Deficit 1.39 1.17 1.64 Do Not Resuscitate Status 0.21 0.08 0.58 Complications Abdominal Compartment Syndrome 3.2 2.21 4.65 Graft/Prosthesis/Flap Failure 2.76 1.63 4.69 Organ/Deep SSI 2.4 1.96 2.93 Superficial SSI 2.53 2 3.2 Decubitus Ulcer 2.17 1.9 2.47 Extremity Compartment Syndrome 1.92 1.44 2.57 Wound Disruption 1.49 1.06 2.09 Myocardial Infarction 1.45 1.11 1.9 Bleeding Complication 1.41 1.12 1.78 Acute Renal Failure 1.18 1.01 1.37 Mechanism of Injury Blunt Ref Penetrating 1.64 1.46 1.85 Burns 0.76 0.53 1.09 PE Risk Factors Severe Injury Severe Superficial Injury (AIS 3) 2.61 1.27 5.35 Comorbidities Unplanned Intubation 2.02 1.33 3.09 Cardiac Arrest with CPR 2.45 1.87 3.2 Decubitus Ulcer 1.41 1.1 1.82 Mechanism of Injury Blunt Ref Penetrating 0.95 0.77 1.17 Burns 0.4 0.19 0.86 Shared Risk Factors Severe Injury Severe Chest Injury (AIS 3) 1.74 1.61 1.88 2.11 1.87 2.39 Severe Abd/Pelvis Injury (AIS 3) 1.94 1.76 2.15 1.86 1.57 2.21 Severe Spine Injury (AIS 3) 1.92 1.73 2.13 1.88 1.59 2.23 Severe LE Injury (AIS 3) 2.17 2.02 2.34 2.55 2.28 2.85 Severe UE Injury (AIS 3) 1.27 1.13 1.43 1.4 1.17 1.69 Comorbidities Hypertension 1.4 1.29 1.52 1.27 1.11 1.46 Obesity 2.2 1.92 2.53 2.12 1.7 2.63 Impaired Sensorium 1.27 1.14 1.43 1.53 1.28 1.82 Current Smoker 1.28 1.12 1.47 1.25 1 1.56 Alcoholism 1.13 1.02 1.26 1.2 1.01 1.43 Complications Pneumonia 2.4 2.2 2.61 2.04 1.74 2.38 ARDS 1.3 1.17 1.45 1.41 1.17 1.7 Stroke/CVA 1.91 1.41 2.59 2.27 1.37 3.76 Systemic Sepsis 1.31 1.14 1.5 1.67 1.33 2.09 Divergent Risk Factor Base Deficit 1.3 1.07 1.58 0.63 0.41 0.97 DVT, deep vein thrombosis; PE, pulmonary emboli; AIS, abbreviated injury scale; ARDS, acute respiratory distress syndrome; CVA, cerebrovascular accident; LE, lower extremity; UE, upper extremity; SSI, surgical site infection; CPR, cardiopulmonary resuscitation. p 0.01 for all risk factors except for steroid use, acute renal failure and bleeding (p = 0.04), dialysis use (p = 0.03), wound disruption, and mechanism of injury for PE (p =0.02).p 0.01 for all risk factors except for alcoholism (p = 0.02). 107

and history of stroke, these were all associated with an increased risk of DVT and not PE. There were no comorbidities that were associated with developing a PE and not a DVT. Compartment syndromes and wound complications accounted for over half the complications that were associated with patients developing a DVT. With regard to PEs, severe superficial injuries, cardiac arrest with cardiopulmonary resuscitation (CPR), and unplanned intubation were all strongly associated with an increased risk of developing a PE and not a DVT. Of all the risk factors studied, there was one that had diverging odds ratios. Base deficit was associated with an increased risk of developing a DVT and a decreased risk for developing a PE. In addition, there was a risk factor that was shared between the two groups that had odds ratios with CIs that did not overlap. Decubitus ulcer was shown to have an odds ratio of 2.17 (CI = 1.9, 2.47) in patients with a DVT, and 1.41 (CI = 1.10, 1.82) in patients with a PE. This was considered a separate risk factor for patients who were diagnosed with a DVT versus a PE as the nonoverlapping CIs are statistically significantly different. DISCUSSION Although there are many overlapping risk factors for patients who are either diagnosed with a PE or DVT, there are independent risk factors that are not shared, and one risk factor with diverging odds ratios, which suggests that the two disease processes are different. Examining the groups separately shows trends that may explain how each group could be a different disease process. Patients diagnosed with deep vein thrombosis appear to have the clinical picture of immobility. These patients have risk factors of presenting with a severe head injury (AIS score of 3), a GCS of <4, compartment syndromes (e.g., abdominal and extremity), and decubitus ulcers, all of which can be associated with immobility. In contrast, patients diagnosed with PE alone are more likely to have cardiac arrest with CPR, and severe superficial injury (AIS score of 3) that includes inhalational injuries. These two risk factors suggest a process more closely related to a chest injury. This is supported by previous work with severe chest injuries being 40% more associated with a PE than a DVT in a previously published NTDB study. 4 In addition, a recently published study by Van Gent et al 5 described patients with chest wall injuries and a higher number of rib fractures and pulmonary contusions being more associated with PE than DVT. In addition to severe chest injury, the previous NTDB study also noted a low overlap in the number of patients diagnosed with a PE and DVT. The lack of overlap between the two groups has been noted in multiple retrospective and prospective clinical studies, with a reported rate of 0 to 22% of patients who were diagnosed with a PE and a concomitant DVT. 2,3,10 12 In one recent study, the authors noted that of the 46 patients identified on retrospective review who underwent a CT angiogram of the chest to diagnose a PE, followed by a CT venogram of the pelvis and lower extremities, only seven patients had a DVT. 2 After ruling out the lack of source of clot from the extremities in a previous study, 13 the authors suspected that PE could be a presentation of a primary hypercoagulable event rather than an embolized thrombus. They hypothesized that a primary pulmonary thrombosis was due to autonomic dysfunction leading to adrenergia and inflammation followed by local vasospasm and eventual thrombosis of the vessel. Although the source of the local autonomic dysfunction was not noted in the article, the data from this study and previous studies 4,5 suggest that severe chest trauma could be a contributing factor. Another possible cause of pulmonary artery thrombosis not related to remote DVTs relates to thrombus being introduced from an external source. Historically, blood products were known to be a source of microthrombi. 14,15 Thrombi would form as a result of the clotting of residual platelets, and white blood cells in the plasma of the blood product (e.g., liquid red blood cells, platelets). Before the use of a filter to remove these thrombi, patients would often have respiratory compromise after the transfusion of blood and PEs were often suspected. 16,17 Considering that blood transfusions are a known risk factor for VTE, 18 20 it is unclear how many current filters decrease the rate or completely eliminate the transfusion of microthrombi. Blood transfusions or other means of resuscitation may explain the sole diverging odds ratio of a base deficit among patients with a VTE. Having a base deficit was associated with an odds ratio of 1.3 in patients with a DVT and 0.63 in patients with a PE. Although this could be considered in conflict with the proposed hypothesis of blood transfusions being a culprit for primary pulmonary thrombosis, this could be due to the way the patients were organized in the model and how base deficit was defined in this dataset. The exact reasoning for the association is not known. Despite the lack of complete overlap of independent risk factors between the two groups, there were many shared statistically significant risk factors that were present in this study (Tables III and IV), most of which have been previously described in current literature. Patients who are older, male, smokers, obese, or have pneumonia have a higher association with developing a VTE. 21 28 In trauma patients, traumatic brain injury, severe spine, chest, pelvic, and extremity fractures have also been previously described as risk factors for VTE. 4,12,29 32 As stated in the methods, this study was not limited to known risk factors for VTE as it would have prevented discovery of new risk factors for PE and/or DVTs. The fact that the statistically significant overlapping risk factors for PE and DVTs are consistent with previously published data implies validation of the model developed for this study. The clinical significance of trying to decipher if PEs could be a primary event is contingent on whether or not a 108

patient would subsequently receive therapeutic anticoagulation or an IVC filter after diagnosis. VTEs are a risk factor in severely injured trauma patients, especially in combat soldiers, who likely have another injury with an increased risk of bleeding (e.g., traumatic brain injury, solid organ injury). IVC filters are often placed in these patients to thwart the bleeding risk of anticoagulation, and possible propagation of a DVT into a PE despite the thrombogenic associated risk. 33 If thrombus within the pulmonary arteries can occur primarily, an IVC filter and therapeutic anticoagulation along with their associated risks may not be indicated. In addition to the clinical significance of primary pulmonary artery thrombosis versus a true PE, there is also a public policy component to the management of the diagnosis. Many governmental agencies, including the Agency for Healthcare Research and Quality and Medicare/Medicaid services consider VTEs as a potential measure of quality, and PE as the most common hospital cause of death. 7 In certain patient populations, PEs and DVTs are considered a never event and are not reimbursed by Centers for Medicare and Medicaid Services. 8 Although, there is no question that DVTs can lead to PEs or at the very least they are a risk factor for developing them, it is unclear how much they contribute to the overall incidence of pulmonary artery thrombosis. Further investigation into the pathophysiology is warranted to not only better understand and treat VTE disease, but to also help guide public policy regarding its management. The greatest limitation of this study is the retrospective blinded design of the NTDB. Review of patient records for further information to help elucidate more specific disease risk factors for PEs and DVTs is not available. Nor is there access to individual hospital policies regarding VTE screening, prophylaxis and treatment algorithms to examine the more unique risk factors discovered in this study. Detection bias could also play a role in this study. For example, patients requiring CPR who have an unplanned intubation are more likely to receive imaging and are, therefore, more likely to be diagnosed with a PE and less likely to be diagnosed with a DVT. Future studies would benefit from prospectively collected data examining the incidence, and examination of clot location and burden to better understand the disease process and address these concerns. Another limitation of the study is that 50% of the original number of patients in the cohort was eliminated from the study due to exclusion criteria and incomplete data. Despite the NTDB being the largest trauma registry in the United States and the world, it is limited by the quality of data submitted by each institution. An attempt to control for data quality resulted in the smaller study population. Nonetheless, this resulted in one of the strengths of this study in that all comorbidities and complications recorded by the NTDB were examined as risk factors and were controlled for confounding variables. CONCLUSION Despite the limitations of the study, mainly the retrospective nature and inability to survey diagnostic modality for VTEs, it shows trends that in conjunction with previously published work that PEs and DVTs may not always be related. In this study of the NTDB cohort between 2007 and 2010, despite patients with a DVT and PE having overlapping risk factors they have many different independent ones. These data further support that PE and DVTs may not always be the same disease process, and draws into question using PEs as a quality reimbursement metric, and whether to consistently treat them with either therapeutic anticoagulation or IVC filters. ACKNOWLEDGMENT We thank Dr. Brian Diggs for his assistance with statistical model development and management of the National Trauma Data Bank. REFERENCES 1. Cervantes J, Rojas G: Virchow s legacy: deep vein thrombosis and pulmonary embolism. World J Surg 2005; 29(Suppl 1): S30 4. 2. Velmahos GC, Spaniolas K, Tabbara M, et al: Pulmonary embolism and deep venous thrombosis in trauma: are they related? Arch Surg 2009; 144: 928 32. 3. Brakenridge SC, Henley SS, Kashner TM, et al: Comparing clinical predictors of deep venous thrombosis versus pulmonary embolus after severe injury: a new paradigm for posttraumatic venous thromboembolism? J Trauma Acute Care Surg 2013; 74: 1231 8; discussion 1237 8. 4. Knudson MM, Gomez D, Haas B, Cohen MJ, Nathens AB: Three thousand seven hundred thirty-eight posttraumatic pulmonary emboli: a new look at an old disease. Ann Surg 2011; 254: 625 32. 5. Van Gent JM, Zander AL, Olson EJ, et al: Pulmonary embolism without deep venous thrombosis: de novo or missed deep venous thrombosis? J Trauma Acute Care Surg 2014; 76: 1270 4. 6. Hutchison TN, Krueger CA, Berry JS, Aden JK, Cohn SM, White CE: Venous thromboembolism during combat operations: a 10-y review. J Surg Res 2014; 187: 625 30. 7. Maynard G, Stein J: Preventing Hospital-Acquired Venous Thromboembolism: A Guide for Effective Quality Improvement. Agency for Healthcare Research and Quality, AHRQ Publication No 8-0075 Rockville, MD, 2008. Available at http://www.ahrq.gov/professionals/ quality-patient-safety/patient-safety-resources/resources/vtguide/index.html; accessed January 19, 2015. 8. Centers for Medicare & Medicaid Services: Medicare and Medicaid Move Aggressively to Encourage Greater Patient Safety in Hospitals and Reduce Never Events, 2008. Available at http://www.cms.gov/ Newsroom/MediaReleaseDatabase/Press-releases/2008-Press-releases-items/ 2008-07-313.html?DLPage=1&DLFilter=hospita&DLSort=0&DLSortDir= descending; accessed November 3, 2014. 9. Kardooni S, Haut ER, Chang DC, et al: Hazards of benchmarking complications with the national trauma data bank: numerators in search of denominators. J Trauma 2008; 64: 273 7; discussion 277 9. 10. Schultz DJ, Brasel KJ, Washington L, et al: Incidence of asymptomatic pulmonary embolism in moderately to severely injured trauma patients. J Trauma Acute Care Surg 2004; 56: 727 33; discussion 731 3. 11. Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD: The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma Acute Care Surg 2002; 52: 453 62. 12. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS: Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg 2004; 240: 490 6; discussion 496 8. 13. Spaniolas K, Velmahos GC, Wicky S, et al: Is upper extremity deep venous thrombosis underdiagnosed in trauma patients? Am Surg 2008; 74: 124 8. 109

14. Solis RT, Gibbs MB: Filtration of the microaggregates in stored blood. Transfusion 1972; 12: 245 50. 15. Goldfinger D, Solis RT, Meryman HT: Microaggregates in frozen and saline washed red blood cells. Transfusion 1974; 14: 151 4. 16. Jenevein EP, Weiss DL: Platelet microemboli associated with massive blood transfusion. Am J Pathol 1964; 45: 313 25. 17. Moseley RV, Doty DB: Death associated with multiple pulmonary emboli soon after battle injury. Ann Surg 1970; 171: 336 46. 18. Gangireddy C, Rectenwald JR, Upchurch GR, et al: Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007; 45: 335 42; discussion 341 2. 19. Cook D, Crowther M, Meade M, et al: Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 2005; 33: 1565 71. 20. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP: A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331: 1601 6. 21. Caprini JA, Arcelus JI, Reyna JJ: Effective risk stratification of surgical and nonsurgical patients for venous thromboembolic disease. Semin Hematol 2001; 38: 12 9. 22. Golomb BA, Chan VT, Denenberg JO, Koperski S, Criqui MH: Risk marker associations with venous thrombotic events: a cross-sectional analysis. BMJ Open 2014; 4: e003208. 23. Soomro Q, Yousuf N, Bhutto AA, Abro HA, Memon AA: Venous thromboembolism (VTE): risk assessment in hospitalized patients. J Coll Physicians Surg Pak 2014; 24: 455 8. 24. Imberti D, Bianchi C, Zambon A, et al: Venous thromboembolism after major orthopaedic surgery: a population-based cohort study. Intern Emerg Med 2012; 7: 243 9. 25. Larsen TB, Sorensen HT, Gislum M, Johnsen SP: Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study. Thromb Res 2007; 120: 505 9. 26. Hansson PO, Eriksson H, Welin L, Svardsudd K, Wilhelmsen L: Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: the study of men born in 1913. Arch Intern Med 1999; 159(16): 1886 90. 27. Scannapieco G, Ageno W, Airoldi A, et al: Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study. Thromb Haemost 2010; 104: 734 40. 28. Rocha AT, Paiva EF, Lichtenstein A, Milani R Jr, Cavalheiro CF, Maffei FH: Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag 2007; 3: 533 53. 29. Malinoski D, Ewing T, Patel MS, et al: Risk factors for venous thromboembolism in critically ill trauma patients who cannot receive chemical prophylaxis. Injury 2013; 44: 80 5. 30. Knudson MM, Collins JA, Goodman SB, McCrory DW: Thromboembolism following multiple trauma. J Trauma Acute Care Surg 1992; 32: 2 11. 31. Giorgi Pierfranceschi M, Donadini MP, Dentali F, et al: The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study. Thromb Haemost 2013; 109: 34 8. 32. O Malley KF, Ross SE: Pulmonary embolism in major trauma patients. J Trauma Acute Care Surg 1990; 30: 748 50. 33. Kim HK, Song I, Jang JH, Oh CW, Lee JM, Huh S: Outcomes of retrievable inferior vena cava filters in patients with deep vein thrombosis and transient contraindication for anticoagulation. Ann Surg Treat Res 2015; 89: 30 6. 110